Atria Investments’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$624K Sell
15,182
-757
-5% -$29.9K 0.01% 1394
2026
Q1
$567K Sell
15,939
-110
-0.7% -$4.12K 0.01% 1380
2025
Q4
$613K Buy
16,049
+8
+0% +$306 0.01% 1319
2025
Q3
$605K Buy
16,041
+2,776
+21% +$102K 0.01% 1321
2025
Q2
$468K Buy
13,265
+2,111
+19% +$69.2K 0.01% 1460
2025
Q1
$360K Buy
11,154
+129
+1% +$4.33K ﹤0.01% 1517
2024
Q4
$367K Sell
11,025
-1,352
-11% -$45.6K ﹤0.01% 1482
2024
Q3
$412K Buy
12,377
+1,255
+11% +$40.2K 0.01% 1430
2024
Q2
$349K Buy
+11,122
New +$337K ﹤0.01% 1501

Other funds holding TCAF

Atria Investments's TCAF Position: Q2 2026 in Review

Atria Investments reduced its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 4.7% in Q2 2026, selling an estimated $29.9K and leaving 15,182 shares worth $624K. The position accounts for 0.01% of the portfolio, ranked #1394.

Atria Investments first reported a position in TCAF in Q2 2024 and has held it in 9 quarters since. 359 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • Atria Investments held 15,182 shares of T. Rowe Price Capital Appreciation Equity ETF worth $624K as of Q2 2026.
  • Atria Investments sold 757 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $29.9K.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1394 holding.
  • Atria Investments first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q2 2024 and has held it in 9 quarters since.
  • 359 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.